Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4f68770578edb0e326a6435d8be304a6 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4726 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-178 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-7056 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1732 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 |
filingDate |
2011-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2017-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_edd2fbb16d66b03f74158f4da1e21fd3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e6097d51ade67fe930d65fa8a292be2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f333d4769a1262460e512843d3f9494 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ae9b54e1c6c808586785c7b1c594ab1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_31e52c616161e64f81a87ad8ea447499 |
publicationDate |
2017-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
RU-2631598-C2 |
titleOfInvention |
Method to increase frequency of embryo implantation in mammal mother uterus, application of effective amount of beta-galactoside-binding lectine or its derivatives, beta-galactosid-binding lectine or derivatives and product |
abstract |
FIELD: medicine. n SUBSTANCE: method is implemented by introduction of an effective amount of beta-galactoside-binding lectin or its alkylated form into the uterus of a mammal before the preimplantation period. The invention relates to application of an effective amount of beta-galactoside-binding lectin or its alkylated form to increase the frequency of embryo implantation in a mammal uterus by implementing the method, as well as to a product for increasing the frequency of embryo implantation in a healthy mammal uterus comprising an effective amount of beta-galactoside-binding lectin or its alkylated form. n EFFECT: product application increases the number of embryonic implants in the uterus. n 17 cl, 2 tbl |
priorityDate |
2010-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |